| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 409.827 | 360.466 | 347.078 | 252.086 | 219.409 | 261.828 | 238.539 | 230.535 | 299.506 | 275.797 |
| Total Income - EUR | 420.472 | 364.171 | 349.350 | 340.797 | 219.860 | 263.159 | 240.884 | 233.076 | 302.522 | 281.961 |
| Total Expenses - EUR | 402.273 | 360.670 | 347.368 | 313.918 | 222.327 | 259.453 | 244.732 | 233.790 | 306.570 | 281.628 |
| Gross Profit/Loss - EUR | 18.199 | 3.500 | 1.982 | 26.880 | -2.467 | 3.706 | -3.848 | -714 | -4.048 | 334 |
| Net Profit/Loss - EUR | 15.287 | 2.921 | 951 | 24.743 | -2.467 | 3.276 | -3.848 | -714 | -4.048 | 281 |
| Employees | 7 | 0 | 6 | 6 | 6 | 6 | 6 | 5 | 5 | 3 |
Check the financial reports for the company - Nordpharm Hd S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 70.503 | 64.114 | 57.454 | 759 | 744 | 15.810 | 12.405 | 9.475 | 10.070 | 5.572 |
| Current Assets | 417.587 | 411.537 | 413.797 | 389.721 | 342.624 | 281.990 | 225.156 | 184.879 | 202.855 | 195.947 |
| Inventories | 56.328 | 39.832 | 38.433 | 28.197 | 27.699 | 33.295 | 29.723 | 31.009 | 32.291 | 26.889 |
| Receivables | 41.966 | 24.059 | 35.922 | 30.005 | 22.719 | 35.001 | 28.279 | 23.375 | 51.586 | 41.321 |
| Cash | 319.293 | 347.646 | 339.442 | 331.520 | 292.206 | 213.695 | 167.154 | 130.495 | 78.546 | 26.421 |
| Shareholders Funds | 421.650 | 403.129 | 397.258 | 366.054 | 329.233 | 282.745 | 217.301 | 150.025 | 145.522 | 114.835 |
| Social Capital | 0 | 223 | 9.851 | 9.670 | 9.483 | 9.303 | 9.097 | 9.125 | 9.097 | 9.046 |
| Debts | 66.440 | 72.522 | 73.993 | 24.426 | 14.135 | 13.762 | 20.527 | 44.549 | 67.621 | 86.973 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 1.551 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Nordpharm Hd S.r.l.